Search results for "esophageal neoplasms"

showing 10 items of 136 documents

Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies

2020

Abstract Background: Obesity is a major risk factor for esophageal adenocarcinoma (EA) and its precursor Barrett's esophagus (BE). Research suggests that individuals with high genetic risk to obesity have a higher BE/EA risk. To facilitate understanding of biological factors that lead to progression from BE to EA, the present study investigated the shared genetic background of BE/EA and obesity-related traits. Methods: Cross-trait linkage disequilibrium score regression was applied to summary statistics from genome-wide association meta-analyses on BE/EA and on obesity traits. Body mass index (BMI) was used as a proxy for general obesity, and waist-to-hip ratio (WHR) for abdominal obesity. …

Male0301 basic medicineOncologymedicine.medical_specialtyEsophageal NeoplasmsEpidemiologyQuantitative Trait LocieducationMedizinMEDLINEGenome-wide association studyAdenocarcinomaPolymorphism Single NucleotideRisk AssessmentLinkage DisequilibriumBody Mass IndexBarrett Esophagus03 medical and health sciencesSex Factors0302 clinical medicineMeta-Analysis as TopicRisk FactorsInternal medicineHumansMedicineGenetic Predisposition to DiseaseObesityEsophagusWaist-Hip Ratiobusiness.industryEsophageal cancermedicine.diseaseMedical researchObesityRenal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11]030104 developmental biologymedicine.anatomical_structureOncology030220 oncology & carcinogenesisBarrett's esophagusDisease ProgressionAdenocarcinomaFemalebusinessGenome-Wide Association StudyCancer Epidemiology, Biomarkers & Prevention
researchProduct

Influence of cell proportions and proliferation rates on FDG uptake in squamous-cell esophageal carcinoma: a PET study.

2008

We investigated the influence of cell proportions and proliferation activities on tumor maximum standard uptake value (SUV(max)) in patients with squamous-cell esophageal cancer (SCEC).Sixteen (16) patients with untreated SCEC were examined with (18)F-flourodeoxyglucose positron emission tomography (FDG-PET). The tumor SUV(max) were calculated. Tumors were resected by transthoracic esophagectomy. Tissues were stained with hematoxylin and eosin for the measurement of cell proportions and MIB-1 for measurement of proliferation indices (PIs). Tumor SUV and histologic data were related by using multiple linear regression analysis.The mean proportion of tumor cells in the tumor site was 58.1% (+…

MaleCancer ResearchPathologymedicine.medical_specialtyEsophageal NeoplasmsCellH&E stainStandardized uptake valueFluorodeoxyglucose F18medicineCarcinomaHumansRadiology Nuclear Medicine and imagingAgedCell ProliferationCell SizePharmacologymedicine.diagnostic_testbusiness.industryFdg uptakeGeneral MedicineEsophageal cancerMiddle Agedmedicine.diseaseImmunohistochemistrymedicine.anatomical_structureOncologyPositron emission tomographyPositron-Emission TomographyCarcinoma Squamous CellMultiple linear regression analysisFemalebusinessCancer biotherapyradiopharmaceuticals
researchProduct

DNA image cytometry. A prognostic tool in squamous cell carcinoma of the esophagus?

1991

In 45 patients who underwent an esophagus resection due to a squamous cell carcinoma, in addition to the TNM classification and usual morphologic criteria, the paraffin-embedded material underwent deparaffinization, was rehydrated, and was mechanically and enzymatically processed into a single-cell solution. For evaluating the DNA histogram this was analyzed with the help of automatic single-cell cytophotometric study. The method, contrary to that of flow cytometric study, allows for the selective analysis of tumor cells due to the electronically, previously given selection criteria, whereas artifacts, stroma, and infection cells remain excluded from analysis. The multivariate analysis show…

MaleCancer ResearchPathologymedicine.medical_specialtyEsophageal NeoplasmsTumor cellsResectionStromaEsophagus CarcinomamedicineHumansBasal cellEsophagusDNA Image CytometryNeoplasm StagingPloidiesbusiness.industryDNA NeoplasmPrognosisSurvival Analysismedicine.anatomical_structureOncologyLymphatic MetastasisCarcinoma Squamous CellFemaleCytophotometrybusinessMedian survivalCancer
researchProduct

The Impact of Endoscopic Ultrasound and Computed Tomography on the TNM Staging of Early Cancer in Barrett's Esophagus

2006

Computed tomography (CT) and endoscopic ultrasound (EUS) are part of the regular staging protocol in esophageal cancer. The value of the two methods was assessed in patients with early cancer in Barrett's esophagus.One hundred consecutive patients (median age 64 yr, interquartile range [IQR] 58-72) with suspected early cancer in Barrett's esophagus who were referred to our hospital for endoscopic therapy were prospectively included in a standardized staging program with upper gastrointestinal endoscopy, EUS (7.5 MHz in all cases plus 12.5 or 20 MHz for elevated and/or depressed lesions), CT of the chest and upper abdomen, and abdominal ultrasonography. The results were summarized in accorda…

MaleEndoscopic ultrasoundmedicine.medical_specialtyEarly cancerEsophageal NeoplasmsAdenocarcinomadigestive systemEndosonographyBarrett EsophagusPredictive Value of TestsmedicineHumansProspective StudiesEsophagusneoplasmsAgedNeoplasm StagingHepatologymedicine.diagnostic_testbusiness.industryEsophageal diseaseUltrasoundGastroenterologyReproducibility of ResultsMiddle Agedmedicine.diseasedigestive system diseasesEndoscopystomatognathic diseasessurgical procedures operativemedicine.anatomical_structureBarrett's esophagusFemaleRadiologyTomographyTomography X-Ray ComputedbusinessThe American Journal of Gastroenterology
researchProduct

Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the …

2015

Abstract Background and purpose We aimed to evaluate the patterns of loco-regional failure (LRF) after exclusive chemoradiotherapy (eCRT) for esophageal cancer with respect to planned dose and/or the incidental (unplanned) dose outside target volumes. Materials and methods Co-image registration of CT or 18 F-FDG PET-CT at the time of failure (tf) and at the time of CRT (t0) was performed in 34 patients with LRF. Dosimetric parameters with regard to local failure (LF), nodal failure (NF) and involved nodal stations (NS) were derived. Results Twenty-two patients (64.7%) had LF, the majority of which (95.5%) were located at the epicenter of the GTV of the primary tumor. The mean doses recalcul…

MaleEsophageal NeoplasmsDose distributionPlanned DoseFluorodeoxyglucose F18MedicineNon metastaticHumansRadiology Nuclear Medicine and imagingIn patientTreatment FailureAgedAged 80 and overbusiness.industryLocal failureRadiotherapy DosageHematologyChemoradiotherapyEsophageal cancerMiddle Agedmedicine.diseasePrimary tumorOncologyFemaleLymph NodesNeoplasm Recurrence LocalbusinessNuclear medicineTomography X-Ray ComputedChemoradiotherapyRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
researchProduct

The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomy

2019

BackgroundComplications after surgery for esophageal cancer are associated with significant resource utilization. The aim of this study was to analyze the economic burden of two frequently used endoscopic treatments for anastomotic leak management after esophageal surgery: Treatment with a Self-expanding Metal Stent (SEMS) and Endoscopic Vacuum Therapy (EVT).Materials and methodsBetween January 2012 and December 2016, we identified 60 German-Diagnosis Related Group (G-DRG) cases of patients who received a SEMS and / or EVT for esophageal anastomotic leaks. Direct costs per case were analyzed according to the Institute for Remuneration System in Hospitals (InEK) cost-accounting approach by c…

MaleEsophageal NeoplasmsEconomicsmedicine.medical_treatmentCancer TreatmentSocial SciencesAnastomotic LeakIndirect costs0302 clinical medicineCost of IllnessMedicine and Health SciencesAged 80 and overMultidisciplinarymedicine.diagnostic_testQREsophageal cancerMiddle AgedSurgical OncologyOncologyEsophagectomy030220 oncology & carcinogenesisMedicine030211 gastroenterology & hepatologyFemaleResearch ArticleClinical OncologyAdultmedicine.medical_specialtyVacuumScienceSelf Expandable Metallic StentsSurgical and Invasive Medical ProceduresAnastomosis03 medical and health sciencesDigestive System ProceduresHealth EconomicsEsophagusAnastomotic leaksmedicineIvor lewisHumansddc:610Agedbusiness.industryStentEndoscopymedicine.diseaseEndoscopySurgeryHealth CareEsophagectomyClinical MedicinebusinessPLoS ONE
researchProduct

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in pat…

2013

Abstract Background This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric junction. Methods Patients received neoadjuvant radiotherapy (50.4 Gy) together with weekly docetaxel (20 mg/m2 at dose level (DL) 1 and 2, 25 mg/m2 at DL 3) and oxaliplatin (40 mg/m2 at DL 1, 50 mg/m2 at DL 2 and 3) over 5 weeks. The primary endpoint was the DLT and the MTD of the RCT regimen. Secondary endpoints included overall response rate (ORR) and progression-free survival (PFS). Results A total of 24 patients were included. F…

MaleOncologyCancer ResearchTime FactorsEsophageal NeoplasmsOrganoplatinum Compoundsmedicine.medical_treatmentMedizinKaplan-Meier EstimateDocetaxellaw.inventionRandomized controlled triallawGermanyProspective StudiesIsraelProspective cohort studyNeoadjuvant therapyChemoradiotherapyMiddle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensNeoadjuvant TherapyOxaliplatinOesophagogastric cancer oxaliplatinTreatment OutcomeDocetaxelOncologyNeoadjuvant radiochemotherapyAdenocarcinomaFemaleTaxoidsEsophagogastric JunctiontherapeuticsResearch Articlemedicine.drugAdultmedicine.medical_specialtyMaximum Tolerated DoseAntineoplastic AgentsAdenocarcinomalcsh:RC254-282Disease-Free SurvivalStomach NeoplasmsInternal medicinemedicineGeneticsHumansddc:610neoplasmsAgedDose-Response Relationship Drugbusiness.industryChemoradiotherapy Adjuvantmedicine.diseasedigestive system diseasesOxaliplatinClinical trialbusinessChemoradiotherapy
researchProduct

Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use?

2006

Histopathological tumor regression grade (TRG) has been shown to be a prognostic factor in patients with esophageal cancer after neoadjuvant radiochemotherapy (RCT). The system introduced by Mandard to group TRG (Cancer 1994;73:2680-2686) has been used to analyse and discuss its prognostic significance on survival in a single institution retrospective analysis: TRG 1 (complete regression) - TRG 5 (absence of regressive changes). Sixty patients with locally advanced (T3/4 or N1) adenocarcinoma or squamous cell carcinoma received cisplatin-based RCT. Three to four weeks later operation for curative intent was performed. Median follow-up was 17.7 months. Histopathological tumor stages were sta…

MaleOncologymedicine.medical_specialtyEsophageal Neoplasmsmedicine.medical_treatment03 medical and health sciences0302 clinical medicineInternal medicineCarcinomaHumansMedicineGrading (tumors)Survival analysisNeoadjuvant therapyNeoplasm StagingRetrospective StudiesTumor Regression GradeUnivariate analysisbusiness.industryGastroenterologyGeneral MedicineMiddle AgedEsophageal cancerPrognosismedicine.diseaseSurvival AnalysisNeoadjuvant Therapy3. Good health030220 oncology & carcinogenesisAdenocarcinomaFemale030211 gastroenterology & hepatologybusinessFollow-Up StudiesDiseases of the Esophagus
researchProduct

In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy.

2006

Background & Aims: Confocal laser endomicroscopy allows subsurface analysis of the intestinal mucosa and in vivo histology during ongoing endoscopy. Here, we have applied this technique to the in vivo diagnosis of Barrett's epithelium and associated neoplasia. Methods: Fluorescein-aided endomicroscopy was performed by applying the endomicroscope over the whole columnar-lined lower esophagus. Images obtained within 1 cm of the columnar-lined lower esophagus were stored digitally and a targeted biopsy examination or endoscopic mucosal resection of the examined areas was performed. In vivo histology was compared with the histologic specimens. All digitally stored images were re-assessed by a b…

MalePathologymedicine.medical_specialtyEsophageal NeoplasmsConfocalContrast MediaEndoscopic mucosal resectionSensitivity and SpecificityEndoscopy GastrointestinalBarrett EsophagusEsophagusIntestinal mucosaPredictive Value of TestsmedicineEndomicroscopyImage Processing Computer-AssistedHumansEsophagusMicroscopy ConfocalMucous MembraneHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyHistologyEquipment DesignMiddle Agedmedicine.diseasedigestive system diseasesEndoscopymedicine.anatomical_structureBarrett's esophagusFemaleFluoresceinGoblet CellsbusinessClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
researchProduct

Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus

2016

Genetic changes involved in the metaplastic progression from squamous esophageal mucosa toward Barrett's metaplasia and adenocarcinoma are almost unknown. Several evidences suggest that some miRNAs are differentially expressed in Barrett's esophagus (BE) and esophageal adenocarcinoma. Among these, miR-143, miR-145, miR-194, miR-203, miR-205, miR-215 appear to have a key role in metaplasia and neoplastic progression. The aim of this study was to analyze deregulated miRNAs in serum and esophageal mucosal tissue biopsies to identify new biomarkers that could be associated with different stages of esophageal disease. Esophageal mucosal tissue biopsies and blood samples were collected and analyz…

MalePathologymedicine.medical_specialtyesophagitisEsophageal NeoplasmsSettore MED/06 - Oncologia MedicaSettore BIO/11 - Biologia MolecolareColumnar-lined oesophaguAdenocarcinomaSettore MED/08 - Anatomia PatologicaEsophageal Diseases03 medical and health sciencesBarrett's esophagus0302 clinical medicineMetaplasiamicroRNAmedicineHumansCirculating MicroRNAEsophagusMetaplasiamicroRNAbusiness.industryEsophageal diseaseEsophagitiBarrett's esophagus; Columnar-lined oesophagus; Esophagitis; Metaplasia; microRNA; OncologyBarrett's esophaguMiddle Agedmedicine.diseaseCirculating MicroRNAmedicine.anatomical_structureOncology030220 oncology & carcinogenesisBarrett's esophaguscolumnar-lined oesophagusDisease ProgressionAdenocarcinoma030211 gastroenterology & hepatologyFemalemedicine.symptombusinessEsophagitisResearch Paper
researchProduct